Effect of vitamin D supplement in regulation of blood pressure
Phase 3
- Conditions
- Essential hypertension.Essential (primary) hypertension
- Registration Number
- IRCT20080901001165N57
- Lead Sponsor
- Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Essential Hypertension (Systolic pressure > 140 mmHg, Diastolic pressure > 90 mmHg)
Adult patients from 18 to 65 y/o
Patients under standard Anti-hypertensive agents
Vitamin D level is less than 30.
Exclusion Criteria
Heart Failure (LVEF<45%)
Renal Failure (Creatinine>1.5mg/dl)
Hepatic Failure
Chronic Obstructive Pulmonary Disease (COPD): (FEV1/FVC <70%)
Thyroid disorders
Hyperparathyroidism
Systemic infection
Hypercalciurea
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Systolic blood pressure. Timepoint: at baseline and 8 weeks after intervention. Method of measurement: Sphygmomanometer, mmHg.;Diastolic blood pressure. Timepoint: at baseline and 8 weeks after intervention. Method of measurement: Sphygmomanometer, mmHg.;Mean arterial pressure. Timepoint: at baseline and 8 weeks after intervention. Method of measurement: Sphygmomanometer, mmHg.;Vitamin D serum level. Timepoint: at baseline and 8 weeks after intervention. Method of measurement: ng/ml.
- Secondary Outcome Measures
Name Time Method Adverse effect of vitamin D supplement. Timepoint: 8 weeks after treatment. Method of measurement: Questionnaire.